Doctors warn that microdosing copycat Ozempic and other GLP-1s is not approved for people with low BMIs and carries risks of ...
As weight-loss drugs grow more popular, experts warn of the risks of using them without supervision for quick, cosmetic ...
At UChicago Medicine, bariatric surgeon Dr. Vanessa Buie treats patients who have reached the maximum GLP-1 dose or hit a ...
There's no doubt that weight-loss jabs such as Mounjaro and Wegovy have completely revolutionised the diet industry.
The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.
Axios on MSN
Weight loss drugs go from niche to mainstream
New pricing deals and aggressive marketing are transforming expensive GLP-1 weight-loss drugs into mainstream treatments and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback